I wonder why only 7 out of the 18 patients showed improvement? What could that mean?
The next step is intervention versus placebo. Strokes are very common. It should be easy to find patients to enroll.
Hopefully this will turn out to work and be worth the cost.
With one intervention using donor cells in 12 months, for stroke patients, that could be a big deal.. with improvement to the procedure or combining with other treatments maybe more could be achieved.